Clovis Oncology Inc (NASDAQ:CLVS)

48.20
Data as of Nov 26
 +0.75 / +1.58%
Today’s Change
35.33
Today|||52-Week Range
93.33
-20.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.6B

Company Description

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. The company has three product candidates in its clinical development pipeline: CO-1686, an oral epidermal growth factor receptor (EGFR), covalent inhibitor currently in Phase I/II development for the treatment of non-small cell lung cancer (NSCLC), in patients with initial activating EGFR mutations as well as the T790M primary resistance mutation; rucaparib, an oral, small molecule poly (ADP-ribose) polymerase (PARP) inhibitor currently in Phase II development for ovarian cancer, which includes the global ARIEL2 (Assessment of Rucaparib in Ovarian Cancer Phase 2 Trial) study; and lucitanib, which is commencing Phase II clinical trials for the treatment of breast and lung cancers. Clovis Oncology was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.

Contact Information

Clovis Oncology, Inc.
2525 28th Street
Boulder Colorado 80301
P:(303) 625-5000
Investor Relations:
(303) 625-5023

Employees

Shareholders

Mutual fund holders40.47%
Other institutional38.64%
Individual stakeholders27.66%

Top Executives

Patrick J. MahaffyPresident, Chief Executive Officer & Director
Erle T. MastChief Financial Officer, Secretary & Executive VP
Andrew R. AllenChief Medical Officer & EVP-Clinical Development
Gillian C. Ivers-ReadChief Regulatory Officer & Executive VP
Steven L. HoerterSenior Vice President-Commercial Operations

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.